Literature DB >> 20720508

Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease.

Birgit Zucker1, Jibrin A Kama, Alexandre Kuhn, Doris Thu, Lianna R Orlando, Anthone W Dunah, Ozgun Gokce, David M Taylor, Johann Lambeck, Bernd Friedrich, Katrin S Lindenberg, Richard L M Faull, Cornelius Weiller, Anne B Young, Ruth Luthi-Carter.   

Abstract

Motor dysfunction, cognitive impairment, and regional cortical atrophy indicate cerebral cortical involvement in Huntington disease (HD). To address the hypothesis that abnormal corticostriatal connectivity arises from polyglutamine-related alterations in cortical gene expression, we isolated layer 5 cortical neurons by laser-capture microdissection and analyzed transcriptome-wide mRNA changes in them. Enrichment of transcription factor mRNAs including foxp2, tbr1, and neuroD6, and neurotransmission- and plasticity-related RNAs including sema5A, pclo, ntrk2, cntn1, and Lin7b were observed. Layer 5 motor cortex neurons of transgenic R6/2 HD mice also demonstrated numerous transcriptomic changes, including decreased expression of mRNAs encoding the Lin7 homolog b ([Lin7b] also known as veli-2 and mals2). Decreases in LIN7B and CNTN1 RNAs were also detected in human HD layer 5 motor cortex neurons. Lin7 homolog b, a scaffold protein implicated in synaptic plasticity, neurite outgrowth, and cellular polarity, was decreased at the protein level in layer 5 cortical neurons in R6/2 mice and human HD brains. Decreases in Lin7b and Lin7a mRNAs were detected in R6/2 cortex as early as 6 weeks of age, suggesting that this is an early pathogenetic event. Thus, decreased cortical LIN7 expression may contribute to abnormal corticostriatal connectivity in HD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720508      PMCID: PMC3376025          DOI: 10.1097/NEN.0b013e3181ed7a41

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  62 in total

1.  Differential morphology of pyramidal tract-type and intratelencephalically projecting-type corticostriatal neurons and their intrastriatal terminals in rats.

Authors:  Anton Reiner; Yun Jiao; Nobel Del Mar; Antonio Vincent Laverghetta; Wan Long Lei
Journal:  J Comp Neurol       Date:  2003-03-17       Impact factor: 3.215

2.  Pyramidal cell loss in motor cortices in Huntington's disease.

Authors:  Virginia Macdonald; Glenda Halliday
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

Review 3.  Molecular organization and assembly of the presynaptic active zone of neurotransmitter release.

Authors:  Anna Fejtova; Eckart D Gundelfinger
Journal:  Results Probl Cell Differ       Date:  2006

4.  A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain.

Authors:  S Butz; M Okamoto; T C Südhof
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

5.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

6.  hFOG-2, a novel zinc finger protein, binds the co-repressor mCtBP2 and modulates GATA-mediated activation.

Authors:  M Holmes; J Turner; A Fox; O Chisholm; M Crossley; B Chong
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

7.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

8.  Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

Authors:  Véronique M André; Carlos Cepeda; Angela Venegas; Yeranui Gomez; Michael S Levine
Journal:  J Neurophysiol       Date:  2005-12-28       Impact factor: 2.714

9.  Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Maria Björkqvist; Asa Petersén; Karl Bacos; Jeremy Isaacs; Per Norlén; Joana Gil; Natalija Popovic; Frank Sundler; Gillian P Bates; Sarah J Tabrizi; Patrik Brundin; Hindrik Mulder
Journal:  Hum Mol Genet       Date:  2006-04-13       Impact factor: 6.150

10.  Functional compensation of motor function in pre-symptomatic Huntington's disease.

Authors:  Stefan Klöppel; Bogdan Draganski; Hartwig R Siebner; Sarah J Tabrizi; Cornelius Weiller; Richard S J Frackowiak
Journal:  Brain       Date:  2009-04-15       Impact factor: 13.501

View more
  7 in total

Review 1.  Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Authors:  Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 2.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

Review 3.  Disrupted striatal neuron inputs and outputs in Huntington's disease.

Authors:  Anton Reiner; Yun-Ping Deng
Journal:  CNS Neurosci Ther       Date:  2018-04       Impact factor: 5.243

4.  LIN7A depletion disrupts cerebral cortex development, contributing to intellectual disability in 12q21-deletion syndrome.

Authors:  Ayumi Matsumoto; Makoto Mizuno; Nanako Hamada; Yasuyuki Nozaki; Eriko F Jimbo; Mariko Y Momoi; Koh-ichi Nagata; Takanori Yamagata
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

Review 5.  Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.

Authors:  Luis M Valor
Journal:  Mol Neurobiol       Date:  2014-05-01       Impact factor: 5.590

6.  Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.

Authors:  Peter McColgan; Sarah Gregory; Kiran K Seunarine; Adeel Razi; Marina Papoutsi; Eileanoir Johnson; Alexandra Durr; Raymund A C Roos; Blair R Leavitt; Peter Holmans; Rachael I Scahill; Chris A Clark; Geraint Rees; Sarah J Tabrizi
Journal:  Biol Psychiatry       Date:  2017-10-26       Impact factor: 13.382

7.  Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Diana A Abbasi; Thu T A Nguyen; Deborah A Hall; Erin Robertson-Dick; Elizabeth Berry-Kravis; Stephanie M Cologna
Journal:  Cerebellum       Date:  2021-05-27       Impact factor: 3.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.